About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Expert Opinion on Therapeutic Patents
›
top-articles
Expert Opinion on Therapeutic Patents
6.4
(top 5%)
impact factor
2.7K
(top 10%)
papers
52.6K
(top 5%)
citations
85
(top 10%)
h
-index
6.6
(top 5%)
impact factor
3.7K
all documents
54.9K
doc citations
118
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Carbonic anhydrase inhibitors and their therapeutic potential
Expert Opinion on Therapeutic Patents
2000
485
2
Antiglaucoma carbonic anhydrase inhibitors: a patent review
Expert Opinion on Therapeutic Patents
2013
273
3
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)
Expert Opinion on Therapeutic Patents
2013
252
4
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Expert Opinion on Therapeutic Patents
2013
246
5
Applications of carbonic anhydrase inhibitors and activators in therapy
Expert Opinion on Therapeutic Patents
2002
243
6
Silver and its application as an antimicrobial agent
Expert Opinion on Therapeutic Patents
2005
237
7
Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013)
Expert Opinion on Therapeutic Patents
2013
226
8
Schiff bases in medicinal chemistry: a patent review (2010-2015)
Expert Opinion on Therapeutic Patents
2017
208
9
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Expert Opinion on Therapeutic Patents
2013
203
10
Sulfonamides: a patent review (2008 – 2012)
Expert Opinion on Therapeutic Patents
2012
201
11
Solid lipid nanoparticles: a review on recent perspectives and patents
Expert Opinion on Therapeutic Patents
2020
179
12
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review
Expert Opinion on Therapeutic Patents
2013
172
13
Therapeutic effects of EGCG: a patent review
Expert Opinion on Therapeutic Patents
2016
167
14
Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016)
Expert Opinion on Therapeutic Patents
2018
165
15
Taxane anticancer agents: a patent perspective
Expert Opinion on Therapeutic Patents
2016
162
16
Recent advances in therapeutic chalcones
Expert Opinion on Therapeutic Patents
2004
160
17
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018)
Expert Opinion on Therapeutic Patents
2018
160
18
Modulation of carbonic anhydrase activity and its applications in therapy
Expert Opinion on Therapeutic Patents
2004
159
19
Carbonic anhydrase inhibitors and activators and their use in therapy
Expert Opinion on Therapeutic Patents
2006
158
20
Recent developments in CCR2 antagonists
Expert Opinion on Therapeutic Patents
2009
158
21
5-Lipoxygenase inhibitors: a review of recent developments and patents
Expert Opinion on Therapeutic Patents
2010
157
22
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review
Expert Opinion on Therapeutic Patents
2011
153
23
Coumarin-based drugs: a patent review (2008 – present)
Expert Opinion on Therapeutic Patents
2012
153
24
Sirtuin activators
Expert Opinion on Therapeutic Patents
2009
150
25
The development of novel therapies for rheumatoid arthritis
Expert Opinion on Therapeutic Patents
2008
147
26
Deuterated drugs: where are we now?
Expert Opinion on Therapeutic Patents
2014
145
27
GPR119 agonists for the treatment of type 2 diabetes
Expert Opinion on Therapeutic Patents
2009
142
28
Piperazine derivatives for therapeutic use: a patent review (2010-present)
Expert Opinion on Therapeutic Patents
2016
140
29
Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity
Expert Opinion on Therapeutic Patents
2003
139
30
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
Expert Opinion on Therapeutic Patents
2018
138
31
Berberine and its derivatives: a patent review (2009 – 2012)
Expert Opinion on Therapeutic Patents
2013
134
32
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Expert Opinion on Therapeutic Patents
2016
134
33
Pharmacological effects of berberine and its derivatives: a patent update
Expert Opinion on Therapeutic Patents
2016
131
34
Betulinic acid and its derivatives: a patent review (2008 – 2013)
Expert Opinion on Therapeutic Patents
2014
128
35
Acetylcholinesterase inhibitors: a patent review (2008 – present)
Expert Opinion on Therapeutic Patents
2012
127
36
Novel sulphonamide derivatives for the treatment of cancer
Expert Opinion on Therapeutic Patents
2000
125
37
Carbonic anhydrase inhibitors: an editorial
Expert Opinion on Therapeutic Patents
2013
125
38
Potential pharmacological uses of chalcones: a patent review (from June 2011 – 2014)
Expert Opinion on Therapeutic Patents
2015
125
39
Topical drug delivery systems: a patent review
Expert Opinion on Therapeutic Patents
2016
123
40
Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer
Expert Opinion on Therapeutic Patents
2002
122
41
Tanshinone II-A: new perspectives for old remedies
Expert Opinion on Therapeutic Patents
2013
122
42
Biodegradable thermosensitive copolymer hydrogels for drug delivery
Expert Opinion on Therapeutic Patents
2007
121
43
Novel therapies for glaucoma: a patent review 2007 – 2011
Expert Opinion on Therapeutic Patents
2012
121
44
Benzofuran derivatives: a patent review
Expert Opinion on Therapeutic Patents
2013
120
45
Biological activities of guanidine compounds
Expert Opinion on Therapeutic Patents
2009
119
46
Multicomponent reactions (MCR) in medicinal chemistry: a patent review (2010-2020)
Expert Opinion on Therapeutic Patents
2021
115
47
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
Expert Opinion on Therapeutic Patents
2011
111
48
Phospholipase A
2
inhibitors as potential therapeutic agents for the treatment of inflammatory diseases
Expert Opinion on Therapeutic Patents
2010
110
49
Recent advances in the therapeutic applications of pyrazolines
Expert Opinion on Therapeutic Patents
2012
109
50
Terpenes and derivatives as a new perspective for pain treatment: a patent review
Expert Opinion on Therapeutic Patents
2014
109
site/software ©
exaly
; All materials licenced under
CC by-SA
.